IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $966 | -99.9% | 25,580 | +39.7% | 0.10% | +26.0% |
| Q2 2022 | $678,000 | +100.0% | 18,310 | +64.5% | 0.08% | +102.6% |
| Q4 2021 | $339,000 | -12.2% | 11,134 | -3.2% | 0.04% | -17.4% |
| Q3 2021 | $386,000 | +56.9% | 11,500 | +122.3% | 0.05% | +15.0% |
| Q3 2020 | $246,000 | -50.1% | 5,174 | -53.8% | 0.04% | -45.2% |
| Q1 2018 | $493,000 | +77.3% | 11,190 | +102.0% | 0.07% | +49.0% |
| Q4 2017 | $278,000 | -2.5% | 5,540 | -1.1% | 0.05% | +6.5% |
| Q3 2017 | $285,000 | -25.2% | 5,600 | -25.3% | 0.05% | -36.1% |
| Q2 2017 | $381,000 | – | 7,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |